165 related articles for article (PubMed ID: 19278424)
1. Concordant overexpression of phosphorylated ATF2 and STAT3 in extramammary Paget's disease.
Chen SY; Takeuchi S; Moroi Y; Hayashida S; Kido M; Tomoeda H; Uenotsuchi T; Tu YT; Furue M; Urabe K
J Cutan Pathol; 2009 Apr; 36(4):402-8. PubMed ID: 19278424
[TBL] [Abstract][Full Text] [Related]
2. Expression of phosphorylated Stat3, cyclin D1 and Bcl-xL in extramammary Paget disease.
Liu HJ; Moroi Y; Masuda T; Yasumoto S; Kokuba H; Imafuku S; Koga T; Tetsuya T; Tu YT; Aburatani H; Furue M; Urabe K
Br J Dermatol; 2006 May; 154(5):926-32. PubMed ID: 16634897
[TBL] [Abstract][Full Text] [Related]
3. Concordant over-expression of transcription factor Sp1 and vascular endothelial growth factor in extramammary Paget's disease.
Chen SY; Takeuchi S; Moroi Y; Hayashida S; Kido M; Uchi H; Takahara M; Uenotsuchi T; Tu YT; Urabe K; Furue M
Int J Dermatol; 2008 Jun; 47(6):562-6. PubMed ID: 18477144
[TBL] [Abstract][Full Text] [Related]
4. Expression of the p38 MAPK, NF-kappaB and cyclin D1 in extramammary Paget's disease.
Lin N; Uchi H; Moroi Y; Fukiwake N; Dainichi T; Takeuchi S; Takahara M; Tu Y; Furue M; Urabe K
J Dermatol Sci; 2007 Mar; 45(3):187-92. PubMed ID: 17207971
[TBL] [Abstract][Full Text] [Related]
5. Expression of insulin-like growth factor-1 receptor, p-AKT and p-ERK1/2 protein in extramammary Paget's disease.
Liu H; Moroi Y; Yasumoto S; Kokuba H; Imafuku S; Koga T; Masuda T; Tu Y; Furue M; Urabe K
Br J Dermatol; 2006 Sep; 155(3):586-91. PubMed ID: 16911286
[TBL] [Abstract][Full Text] [Related]
6. Expression and prognostic significance of Stat5a and E-cadherin in extramammary Paget's disease.
Liu H; Urabe K; Uchi H; Takeuchi S; Nakahara T; Dainichi T; Tu Y; Furue M; Moroi Y
J Cutan Pathol; 2007 Jan; 34(1):33-8. PubMed ID: 17214852
[TBL] [Abstract][Full Text] [Related]
7. High expression of Ki-67 and cyclin D1 in invasive extramammary Paget's disease.
Aoyagi S; Akiyama M; Shimizu H
J Dermatol Sci; 2008 Jun; 50(3):177-84. PubMed ID: 18248961
[TBL] [Abstract][Full Text] [Related]
8. Concordant overexpression of p-FAK and p-ERK1/2 in extramammary Paget's disease.
Chen SY; Moroi Y; Urabe K; Takeuchi S; Kido M; Hayashida S; Uchi H; Uenotsuchi T; Tu YT; Furue M
Arch Dermatol Res; 2008 Apr; 300(4):195-201. PubMed ID: 18210145
[TBL] [Abstract][Full Text] [Related]
9. Extramammary Paget's disease: analysis of growth signal pathway from the human epidermal growth factor receptor 2 protein.
Ogawa T; Nagashima Y; Wada H; Akimoto K; Chiba Y; Nagatani T; Inayama Y; Yao M; Aoki I; Ikezawa Z
Hum Pathol; 2005 Dec; 36(12):1273-80. PubMed ID: 16311120
[TBL] [Abstract][Full Text] [Related]
10. PI3K, Rac1 and pPAK1 are overexpressed in extramammary Paget's disease.
Qian Y; Zhang N; Chen S; Chu S; Feng A; Liu H
J Cutan Pathol; 2012 Nov; 39(11):1010-5. PubMed ID: 22845716
[TBL] [Abstract][Full Text] [Related]
11. Matrilysin-1 (MMP-7) and MMP-19 are expressed by Paget's cells in extramammary Paget's disease.
Kuivanen T; Tanskanen M; Jahkola T; Impola U; Asko-Seljavaara S; Saarialho-Kere U
J Cutan Pathol; 2004 Aug; 31(7):483-91. PubMed ID: 15239678
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of phosphorylated-STAT3 and phosphorylated-ERK protein in dermatofibrosarcoma protuberans.
Lin N; Urabe K; Moroi Y; Uchi H; Nakahara T; Dainichi T; Kokuba H; Tu Y; Furue M
Eur J Dermatol; 2006; 16(3):262-5. PubMed ID: 16709490
[TBL] [Abstract][Full Text] [Related]
13. Prostate-specific antigen-positive extramammary Paget's disease--association with prostate cancer.
Hammer A; Hager H; Steiniche T
APMIS; 2008 Jan; 116(1):81-8. PubMed ID: 18254784
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of phosphorylated-ATF2 and STAT3 in cutaneous angiosarcoma and pyogenic granuloma.
Chen SY; Takeuchi S; Urabe K; Hayashida S; Kido M; Tomoeda H; Uchi H; Dainichi T; Takahara M; Shibata S; Tu YT; Furue M; Moroi Y
J Cutan Pathol; 2008 Aug; 35(8):722-30. PubMed ID: 18700251
[TBL] [Abstract][Full Text] [Related]
15. Expression and prognostic value of activating transcription factor 2 (ATF2) and its phosphorylated form in mammary carcinomas.
Knippen S; Löning T; Müller V; Schröder C; Jänicke F; Milde-Langosch K
Anticancer Res; 2009 Jan; 29(1):183-9. PubMed ID: 19331149
[TBL] [Abstract][Full Text] [Related]
16. Expression of survivin and human telomerase reverse transcriptase in extramammary Paget's disease.
Shan SJ; Zhang N; Geng SL; Zhou Z; Chen X; Nie T; Guo Z; Li C; Liu Q; Guo Y; Wei H; Chen HD
J Cutan Pathol; 2010 Jun; 37(6):635-40. PubMed ID: 19788441
[TBL] [Abstract][Full Text] [Related]
17. Cytokeratin 7 staining in mammary and extramammary Paget's disease.
Smith KJ; Tuur S; Corvette D; Lupton GP; Skelton HG
Mod Pathol; 1997 Nov; 10(11):1069-74. PubMed ID: 9388055
[TBL] [Abstract][Full Text] [Related]
18. Frozen section-guided wide local excision in the treatment of penoscrotal extramammary Paget's disease.
Zhu Y; Ye DW; Chen ZW; Zhang SL; Qin XJ
BJU Int; 2007 Dec; 100(6):1282-7. PubMed ID: 17850363
[TBL] [Abstract][Full Text] [Related]
19. The expression of HER-2 in extramammary Paget's disease.
Masuguchi S; Jinnin M; Fukushima S; Makino T; Sakai K; Inoue Y; Igata T; Ihn H
Biosci Trends; 2011 Aug; 5(4):151-5. PubMed ID: 21914949
[TBL] [Abstract][Full Text] [Related]
20. Differential expression of mucin core proteins and keratins in apocrine carcinoma, extramammary Paget's disease and apocrine nevus.
Miyamoto T; Inoue S; Adachi K; Takada R
J Cutan Pathol; 2009 May; 36(5):529-34. PubMed ID: 19476520
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
